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While osteo- and chondro-inductive activities of recombinant human bone morphogenetic protein
7 are well established, evaluation of the role of endogenous BMP7 in skeletal homeostasis has been
hampered by perinatal lethality in BMP7 knockout mice. Here, we examined physiological roles of
endogenous BMP7 in joint homeostasis and showed that proteoglycan contents in articular cartilage
were signiﬁcantly reduced in the absence of BMP7. Loss of BMP7 did not affect survival of articular
cartilage cells, but resulted in reduced expression of aggrecan and enhanced expression of matrix
metalloproteinase 13. We also found extensive synovial hyperplasia and enhanced expression of
Activin A. These ﬁndings suggest that locally produced BMP7 is prerequisite for postnatal synovial
joint homeostasis and may be involved in osteoarthritic changes in adults.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction cartilage function is the most urgent and challenging need in thisOsteoarthritis (OA) is a degenerative joint disease that severely
decreases the activity of daily life (ADL). More than 25 million
people suffer from OA, with prevalence in men and women over
40 years of age of 42.6% and 62.4%, respectively in Japan [1].
Although OA is multifactorial in initiation, articular cartilage
degeneration is a major cause of OA, and maintenance of articularﬁeld.
Bone morphogenetic proteins (BMPs), multifunctional signaling
molecules belonging to the transforming growth factor (TGF)-b
gene superfamily, were identiﬁed by their ability to induce ectopic
bone and cartilage in vivo [2–4]. We and other research groups
have reported that osteogenic BMPs such as BMPs 2, 4, 5, 6, and
7 are expressed and play important roles during skeletogenesis
and in postnatal bone homeostasis [5–14]. In addition, proper
BMP signaling is required for postnatal joint homeostasis as
Rountree et al. showed that articular cartilage gradually wears
away in the absence of type Ia BMP receptor (Alk3) [15]. Among
the BMPmolecules, bone morphogenetic protein 7 (BMP7) is abun-
dantly expressed in articular cartilage and synovial membrane
obtained from patients undergoing autologous chondrocyte
implantation [16]. Intra-articular injection of recombinant human
BMP7 protein (rhBMP7) has been shown to promote survival of
articular chondrocytes in an acute cartilage trauma model in sheep
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tion of rhBMP7 signiﬁcantly inhibited articular cartilage degenera-
tion and osteophyte formation within the joint [18,19], and also
blocked production of inﬂammatory cytokines by the synovial
membrane [20] in vivo. These results strongly suggest that BMP7
may have a unique and pivotal role(s) in joint homeostasis through
its anabolic/anti-catabolic, anti-apoptotic, and anti-inﬂammatory
effects on speciﬁc joint tissues.
In spite of evidence that treatment with rhBMP7 positively
affects joint homeostasis, the role(s) of endogenous locally pro-
duced BMP7 in this process have not been studied extensively. To
deﬁne the role(s) of BMP7 in postnatal bone and joint homeostasis,
we established limbmesenchyme-speciﬁc BMP7 conditional knock-
out (Bmp7c/c;Prx1::cre) mice by breeding the mice carrying ﬂoxed
Bmp7 alleles and cre recombinase driven by Prx1 enhancer and pre-
viously reported that endogenous BMP7 activity was dispensable in
both skeletal development and postnatal bone homeostasis includ-
ing the process of fracture healing [13]. Here we show that the
absence of BMP7 led to a signiﬁcant reduction in the amount of pro-
teoglycan and aggrecan present in articular cartilage while the car-
tilage degrading enzyme, matrix metalloprotease 13 (MMP-13), is
increased. We also observe extensive synovial hyperplasia and
macrophage inﬁltration. Our data strongly suggest that loss of
locally produced BMP7 leads to degenerative changes in articular
cartilage that correlate with the development of age-related OA.
2. Materials and methods
2.1. Animals
All mouse experiments were approved and conducted in accor-
dance with the guidelines of the animal committee of Tokyo
Medical and Dental University.
Limb speciﬁc Bmp7c/c;Prx1::cremicewere generated as described
previously [13,21,22]. Brieﬂy, mice carrying a ﬂoxed allele of
BMP7 were bred to Prx1::cre mice to obtain Bmp7c/c;Prx1::cremice.
Mouse genotypes were determined as described previously [13].
Mice were housed under a 12-h light–dark cycle and allowed food
and water ad libitum. Littermates not expressing cre recombinase
were designated as experimental controls.
2.2. Histology
Bmp7c/c;Prx1::cre and control mice were sacriﬁced at 4, 8 and
24 weeks of age. The right hind limb of each experimental sample
was ﬁxed in 4% paraformaldehyde (PFA), de-calciﬁed, and embed-
ded in parafﬁn [23]. Five lm sagittal sections were prepared from
the medial side of the knee joint, de-parafﬁnized in xylene, re-
hydrated through graded alcohols, and stained with safranin-o/fast
green or hematoxylin/eosin to evaluate the morphological changes
of knee joint. All sections in this study were visualized by using an
Olympus BX 53 microscope (Olympus, Tokyo, Japan).
2.3. Semi quantitative evaluation of cartilage degeneration and
synovial inﬂammation
The severity of articular cartilage degeneration was assessed
according to modiﬁed Mankin’s scoring system (Supplemental
Table 1) [24]. The severity of cell inﬁltration and synovial hyper-
plasia was assessed according to a validated synovitis scoring
system (Supplemental Table 2) [25].
2.4. Immunohistochemistry
Immunohistological analyses were performed as described pre-
viously [23]. Brieﬂy, de-parafﬁnized and re-hydrated sections werepretreated with 0.4 mg/ml of proteinase K (DAKO, Carpinteria, CA,
USA) in Tris–HCl buffer for 5 min at room temperature for antigen
retrieval. All subsequent incubations were performed in a humidi-
ﬁed chamber. Endogenous peroxidases were quenched using 0.3%
hydrogen peroxidase in methanol for 30 min at room temperature.
Any residual enzymatic activity was removed by washing with
phosphate-buffered saline (PBS), and non-speciﬁc antigen was
blocked by pre-incubation with PBS containing 0.5% normal goat
serum (Vector: S-1000, CA, USA) for type II collagen, normal rabbit
serum (Vector: S-5000) for F4/80, or normal horse serum (Vector:
S-5000) for PCNA (Proliferating Cell Nuclear Antigen) for 30 min at
room temperature. Then, the sections were incubated with rabbit
polyclonal anti-mouse type II collagen antibody (1:1000 dilution;
Abcam:ab34712, Cambridge, UK), rat anti-mouse F4/80 antibody
(1:2000 dilution; AbD Serotec MCA497), or rabbit polyclonal
anti-mouse PCNA antibody (1:200 dilution; Abcam:ab53048,
Cambridge, UK) at 4 C overnight. After extensive washing with
PBS, the sections were incubated with the secondary antibody of
goat poly-biotinylated anti-rabbit IgG (1:200 in dilution; Vector:
BA-6100) for type II collagen, with the secondary antibody of rabbit
poly-biotinylated anti-rat IgG (1:200 in dilution; Vector: BA-4000)
for F4/80, or with the secondary antibody of horse poly-biotiny-
lated anti-rabbit IgG (1:200 in dilution; Vector: BA-4000) for
PCNA for 30 min at room temperature. Signals were visualized by
Vectastain ABC reagent (Vector: PK-6100) followed by DAB stain-
ing. Sections were counter stained with hematoxylin.
2.5. Meniscus morphology, cartilage thickness and chondrocyte
density analyses
Morphological parameters are evaluated as described by Matsui
et al. [26]. To evaluate the meniscus morphology, cartilage thick-
ness, and chondrocyte density, images of meniscus (as shown in
Fig. 3A) were captured, and an area of articular cartilage and adja-
cent subchondral bone between the anterior and posterior edges
of meniscus (217.5 lm in width, as shown in Fig. 2E) was selected.
Axio vision software (Carl Zeiss, Jena, Germany) was employed for
the evaluation of meniscus morphological parameters (area, length
and width) as well as the area of articular cartilage. Average articu-
lar cartilage thickness was calculated by dividing the articular car-
tilage area by the width. Chondrocytes were counted and divided
by articular cartilage area to obtain chondrocyte density.
2.6. Cell apoptosis assay
The cell apoptosis assay was performed using a TUNEL detec-
tion kit according to the manufacturer’s instructions (Takara
Shuzo, Kyoto, Japan). Brieﬂy, sections were de-parafﬁnized in
xylene, rehydrated through graded alcohol, and incubated with
15 mg/ml of proteinase K for 15 min at room temperature. Then
the sections were immersed in TdT enzyme diluted with Labeling
Safe Buffer (provided in the kit) and incubated for 90 min at
37 C in a humidiﬁed chamber. Signals were detected by ﬂuores-
cence microscopy (Olympus BX 53, Tokyo, Japan). For the staining
control, a positive control section which was provided within the
kit was used.
2.7. Micro computed tomography (lCT) analysis
To analyze the morphometric changes of epiphyseal trabecular
bone structures in the presence or absence of BMP7, left tibiae
were harvested and ﬁxed in 70% ethanol. Three dimensional skele-
tal imaging was captured using a lCT apparatus (Scan Xmate-
E090; Comscan Techno Co, Kanagawa, Japan). Epiphyseal trabecu-
lar bone volume per tissue volume (BV/TV), trabecular thickness
(Tb.Th.), trabecular number (Tb.N) and trabecular spacing
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System Engineering Co., Tokyo, Japan).
2.8. RNA extraction and quantitative real-time PCR
Articular cartilages and synovial membranes were collected
from mice knee joints (n = 4) and homogenized in TRIzoll reagent
(Ambion, Life Tech, Auckland, USA) with a micro homogenizer
(NS-310E) immediately after the harvest. Total RNA was further
puriﬁed using High Pure RNA Isolation Kit (Roche, Mannheim,
Germany). Complementary DNA was synthesized using
Transcriptor High Fidelity cDNA Synthesis Kit (Roche, Mannheim,
Germany). Amount of each mRNA was quantitated by
LightCycler 480 Real-Time PCR System (Roche, Germany) using
FastStart TaqManProbe Master Kit (Roche, Mannheim,
Germany). Relative mRNA expression level was normalized against
endogenous beta-actin as previously described [27]. Sequences of
PCR primers were indicated in Supplemental Table 3.
2.9. Statistical analysis
All data are expressed as mean with standard error. The signiﬁ-
cance of difference was assessed by the Mann–Whitney U test with
differences considered to be signiﬁcant at P < 0.05.
3. Results
3.1. Elimination of BMP7 expression from the developing limb
mesenchyme leads to articular cartilage degeneration after
adolescence
Using Prx1::cre deleter mice, we successfully eliminated most of
the BMP7 expression (more than 95%) in articular cartilage (Fig. 1A),
which was also conﬁrmed by whole mount in situ hybridization
during the developing limb in our previous report (13).
Histological analyses revealed that loss of BMP7 expression from
the limbmesenchyme had subtle, if any, effect on articular cartilage
formation since we did not observe any signiﬁcant alteration in
safranin-o dye-ability and type II collagen expression in cartilage
at 4 weeks of age when the joint formation had completed
(Fig. 1B and D). Semi-quantitative evaluation (Mankin’s score) con-
ﬁrmed these histological ﬁndings (Fig. 1C). In contrast, we observed
signiﬁcant loss of proteoglycan content in articular cartilage of
Bmp7c/c;Prx1::cremice at 8 weeks (Fig. 2A and B). Since hypertrophic
differentiation and cloning (clustering) of articular chondrocytes as
well as reduction of cartilage thickness are usually observed during
the process of primary OA, we further analyzed the articular carti-
lage at a cellular level. As shown in Fig. 2C and D, we did not observe
any signiﬁcant progression of hypertrophic differentiation and
chondrocyte proliferation, nor did we see a change in the average
thickness of the articular cartilage of the femur or the tibia
(Fig. 2E and F) at this age. At 24 weeks, we also observed severe
reduction in proteoglycan context in articular cartilage matrices in
Bmp7c/c;Prx1::cre mice (Supplemental Fig. 1A), but again did not
observe clear progression of articular cartilage degeneration as
measured by Mankin’s score (compare Supplemental Figs. 1B and
2B), or average thickness of articular cartilage between the
genotype (compare Supplemental Figs. 1C and 2F). PCNA staining
further supports subtle effects on chondrocyte proliferation in
Bmp7c/c;Prx1::cre mice (Supplemental Fig. 1D and E).
3.2. Morphological and histological features of meniscus and
subchondral bone in Bmp7c/c;Prx1::cre and control mice
Since reduced meniscal function due to injury or malformation
is recognized as important risk factors for articular cartilagedegeneration [28–31], we performed detailed morphological
analyses of meniscus. As shown in Fig. 3A and B, we did not
observe any signiﬁcant difference in size (area) and shape (length
and width) of medial meniscus in the absence of BMP7 at
24 weeks. Sagittal sections of anterior region of medial meniscus
also revealed that no morphological alteration was observed in
Bmp7c/c;Prx1::cremice, although safranin-o dye-ability was slightly
decreased in the absence of BMP7 (Fig. 3C arrowheads). We did not
observe any signiﬁcant alteration in type II collagen expression in
this region (Fig. 3C lower panels).
As subchondral bone sclerosis is associated with the progres-
sion of OA [32], we also examined the trabecular bone density in
the epiphyseal region of tibia in Bmp7c/c;Prx1::cremice at 24 weeks
of age. Micro-CT analyses indicated that no signiﬁcant alteration in
trabecular bone structures is observed between the genotype
(Fig. 3D and E). In addition, we did not observe osteophyte forma-
tion at any stages in the absence of Bmp7 (data not shown).
These data suggest that the cartilage degeneration observed in
Bmp7c/c;Prx1::cre mice is not likely due to developmental (Fig. 1)
or structural abnormalities (Fig. 3) of the joint tissues, suggesting
a direct role for BMP7 in the maintenance of articular cartilage.
3.3. Loss of BMP7 from the knee joint has no effect on chondrocyte
survival, however alters both cartilage matrix protein expression and
cartilage matrix degrading enzyme expression
Next, to clarify the functions of endogenous BMP7 in knee joint
homeostasis, we further analyzed the articular cartilage at the
molecular and cellular levels. As rhBMP7 is a potent anti-apoptotic
regulator for articular chondrocytes, and also enhances cartilage
matrix production while inhibiting cartilage matrix degradation,
we focused on these cellular functions.
As shown in Fig. 4A, we did not observe any TUNEL-positive
apoptotic cell in the articular cartilage of both Bmp7c/c;Prx1::cre
mice and control littermates at 8 weeks. In addition, expression
of apoptosis-related cysteine proteases, such as caspase3 and cas-
pase8, was not altered in the absence of BMP7 (Fig. 4B). These data
suggest that endogenous BMP7 activity may not be involved in the
chondrocyte survival. To examine if endogenous BMP7 activity is
involved in regulation of the expression of cartilage matrix pro-
teins and/or cartilage matrix degrading enzymes, we extracted
total RNA from articular cartilage and performed gene expression
analyses. At 8 weeks, we did not observe any signiﬁcant alteration
in expressions of cartilage matrix proteins or matrix degrading
enzymes (Fig. 4C). This situation changed as the mice aged, and
at 24 weeks, we observed a signiﬁcant decrease in aggrecan gene
expression concomitant with an increase in matrix metallopro-
teinase 13 expression (Fig. 4D). These data suggest that endoge-
nous BMP7 activity may act as an anabolic and anti-catabolic
regulator for mature articular cartilage.
3.4. Synovial auto-inﬂammation and hyperplasia are observed in the
absence of endogenous BMP7
Synovial inﬂammation and synovial hyperplasia are usually
associated with the progression of OA [33]. So, we examined the
synovial membranes of mice lacking BMP7 for potential changes.
As shown in Fig. 5A, the cellularity of the synovial membrane
was quite similar in the presence or absence of BMP7 in young
mice (4 weeks of age; higher magniﬁcation in the middle panels),
although there was a slightly increased accumulation of F4/80-
positive macrophages in the absence of BMP7 (lower panels). At
8 and 24 weeks of age, we observed extensive synovial hyperplasia
(middle panels) and signiﬁcant numbers of F4/80 positive-
macrophage inﬁltrating into the synovial membrane in
Bmp7c/c;Prx1::cre mice (Fig. 5B), although the severity of synovial
Fig. 1. Elimination of BMP7 expression from the developing limb mesenchyme did not affect knee joint formation. (A) BMP7 gene expression in articular cartilage at 8 and
24 weeks of age quantitated by Q-PCR. Values were represented by mean ± SE (n = 4). (B) Safranin-O staining of sagittal sections of knee joint at 4 weeks of age. Sections were
counterstained by fast green. Upper; femur, lower; tibia. Boxed area in low-power ﬁeld was indicated in high-power ﬁeld. A scale bar in high-power ﬁeld (20) indicates
50 lm, in low-power ﬁeld (4) indicates 200 lm. (C) Semi-quantitative evaluation of articular cartilage degeneration by modiﬁed Mankin’s scoring system. Values were
represented as mean ± SE (n = 3). (D) Type II collagen expression in knee joint at 4 weeks of age. Boxed area in low-power ﬁeld was indicated in high-power ﬁeld. A scale bar
in high-power ﬁeld (20) indicates 50 lm, in low-power ﬁeld (4) indicates 200 lm. Asterisks indicate P < 0.05.
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histological observations were conﬁrmed using a semi-quantita-
tive synovitis scoring system; we observed signiﬁcant increases
in synovitis scores in Bmp7c/c;Prx1::cremice at both 8 and 24 weeks
(Fig. 5D–F). Gene expression analyses indicated that among the
proinﬂammatory cytokines present, Activin A expression was sig-
niﬁcantly increased in synovial membrane from Bmp7c/c;Prx1::cre
mice at 24 weeks while we observed comparable levels of IL-1b
between the genotype (Fig. 5G). These data suggest that endoge-
nous BMP7 has anti-inﬂammatory effects that dampen the syn-
ovial hyperplasia often seen in aging mice.4. Discussion
Our study is the ﬁrst to describe a physiological role for locally
produced BMP7 in the maintenance of synovial joint homeostasis
in adults. These results are in line with the phenotype of joint
speciﬁc Alk3 conditional knockout mice, where joint formation
occurs but the joint structures gradually decline with age [15].
The joint phenotype we observed in the absence of BMP7 is much
milder than that reported for loss of Alk3, consistent with the
knowledge that other osteogenic BMPs such as BMP2 and BMP4,
are also ligands for Alk3, and are also present in articular cartilage
Fig. 2. Elimination of BMP7 expression from the developing limb mesenchyme leads to articular cartilage degeneration at 8 weeks of age. (A) Safranin-O staining of sagittal
sections of knee joint. Sections were counterstained by fast green. Upper; femur, lower; tibia. Arrowheads indicate the region where proteoglycan contents were decreased.
Boxed area in low-power ﬁeld was indicated in high-power ﬁeld. A scale bar in high-power ﬁeld (20) indicates 50 lm, in low-power ﬁeld (4) indicates 200 lm. (B) Semi
quantitative evaluation of articular cartilage degeneration by modiﬁed Mankin’s scoring system. Values were represented as mean ± SE (n = 7). (C) H/E staining of sagittal
sections of knee joint. Boxed area in low-power ﬁeld was indicated in high-power ﬁeld. A scale bar in high-power ﬁeld (40) indicates 20 lm, in low-power ﬁeld (4)
indicates 200 lm. (D) Chondrocyte density in articular cartilage. Number of chondrocytes in the high-power ﬁeld (boxed area in the low-power ﬁeld) was counted and
plotted. Values were represented as mean ± SE (n = 7). (E, F) Area of articular cartilage was contoured as indicated in panel E and quantitated by Zeiss Axio Vision. A scale bar
in high-power ﬁeld (40) indicates 20 lm, in low-power ﬁeld (4) indicates 200 lm. Average cartilage thickness was calculated as described in materials and methods.
Values were represented as mean ± SE (n = 7). Double asterisks indicate P < 0.01. SCB; subchondral bone.
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loss of BMP2 from the developing limb (Bmp2c/c;Prx1::cre), did
not affect joint formation during embryogenesis, but caused a
delay in secondary ossiﬁcation center formation and reduced type
II collagen expression from articular cartilage by 2 weeks of age
[11]. As loss of BMP7 did not result in changes in type II collagen
expression (Figs. 1D, 4C and D and Supplemental Fig. 2), our
data suggest that each BMP molecule may have distinct function
in cartilage based on their temporal and spatial expression
patterns.
Our histological analyses indicated that cartilage morphology
and thickness were quite normal in the absence of BMP7, as was
the morphology of the medial meniscus and the underlyingsubchondral bone, suggesting that along with endogenous BMP7
activity, other factors are also necessary for the progression of
OA. This idea is supported by epidemiological analyses of OA that
show it to be a multifactorial diseases affected by diverse factors
such as age, hormone status, body weight, heredity, hypertension,
and abnormal mechanical stress [34–39]. We believe that BMP7
status is an additional component to OA susceptibility and expect
that genetic/epi-genetic analyses of BMP7 gene locus may give us
important information to predict the prevalence of OA.
In our study, endogenous BMP7 activity was not directly
involved in the proliferation, hypertrophic differentiation, and sur-
vival of articular chondrocytes, ﬁndings that are in stark contrast to
data reported previously by other groups [17,40–42]. We predict
Fig. 3. Histomorphometrical analysis of medial meniscus and epiphyseal trabecular bone of Bmp7c/c;Prx1::cre mice at 24 weeks of age. (A) Superior view of tibial plateau of
control and Bmp7c/c;Prx1::cre mice at 24 weeks of age. Medial meniscus was contoured by dotted lines. A scale bar indicates 500 lm. (B) Morphological evaluation of medial
meniscus. Area, length and width of medial meniscus were measured based on the macroscopic observation (n = 9). (C) Histological analysis of anterior medial meniscus.
Upper panels; safranin-O staining of sagittal sections of anterior medial meniscus. Sections were counterstained by fast green. Boxed areas in low-power ﬁeld (4) were
indicated in high-power ﬁeld (10). Arrowheads indicated reduced safranin-o dye-ability in Bmp7c/c;Prx1::cre. Lower panels; type II collagen immuno-staining. A scale bar in
high-power ﬁeld (10) indicates 100 lm, in low-power ﬁeld (4) indicates 200 lm. (D, E) Bone histomorphometrical analysis of tibia epiphysis by lCT. Histomorphometrical
parameters in trabecular bone area highlighted by white in panel D was quantitated and plotted in panel E. Values represent mean ± SE (n = 9).
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Fig. 4. Effects of endogenous BMP7 on chondrocyte survival and gene expression proﬁles. (A) TUNEL staining of articular cartilage at 8 weeks. Cells with green ﬂuorescence
undergo death by apoptosis. Scale bar in pictures (10) indicates 100 lm (B) Apoptosis-related gene expression in articular cartilage at 8 weeks (n = 4). (C, D) Anabolic- and
catabolic-gene expressions in articular cartilage at 8 and 24 weeks (n = 4). Values represent mean ± SE. Asterisk indicates P < 0.05.
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between endogenously expressed BMP7 and the amount used for
intra-articular injections.
Our data are consistent with a role for rhBMP7 in both anabolic
and anti-catabolic functions in articular cartilage [43,44]. It is also
possible that cells other than articular chondrocytes may be targets
for BMP7 in the adult synovial joint. One interesting candidate is
synovial macrophage, as this cell type is observed in higher
abundance in 8 week-old Bmp7c/c;Prx1::cre mice. These cells mayalso be the source of the proinﬂammatory cytokine, Activin A,
whose expression was signiﬁcantly increased in the absence of
BMP7. Since reduction of articular cartilage proteoglycan content
was observed at the same time as higher Activin A production,
we hypothesize that the synovial inﬂammation observed in
Bmp7c/c;Prx1::cre mice is due to enhanced auto-inﬂammatory
responses.
In summary, we showed that the absence of BMP7 in the
knee joint results in signiﬁcant loss of proteoglycan from
Fig. 5. Elimination of BMP7 expression from the developing limb mesenchyme leads to auto-inﬂammation in synovial membrane after 8 weeks. (A, B, C) H/E staining of
sagittal sections of knee joint at 4, 8, and 24 weeks. Boxed areas in upper panels were magniﬁed and indicated in the middle panels. Immunohistochemical staining of
synovial membrane by mouse macrophage-speciﬁc f4/80 antibody (lower panels). A scale bar in high power ﬁeld (40) indicates 20 lm, in low power ﬁeld (4) indicates
200 lm (D, E, F) Semi-quantitative analyses of the severity of synovial inﬂammation by synovitis scoring system. (4 weeks; n = 3, 8 weeks; n = 7, 24 weeks; n = 9). (G) Activin
and IL-1b expression in synovial membrane of Bmp7c/c;Prx1::cre mice and control littermates at 24 weeks of age quantitated by Q-PCR. Values represent mean ± SE. Asterisk
indicates P < 0.05. (n = 4).
K. Abula et al. / FEBS Letters 589 (2015) 1240–1248 1247articular cartilage and also correlates with an increased synovial
auto-inﬂammatory response in adult mice. Our results are
consistent with a role for endogenous BMP7 activity in synovial
joint homeostasis. Since rhBMP7 is currently available for clinical
use, we believe that it may be beneﬁcial to supplement endoge-
nous BMP7 with rhBMP7 to prevent or slow the development of
primary OA.
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